Lead clinical pharmacology modeling and simulation efforts for infectious disease assets, combining hands-on pharmacometric analysis with strategic input across clinical development. Design and interpret studies, develop population PK/PD models, and guide dose selection and regulatory strategies. Work within cross-functional teams to influence development decisions and advance model-informed drug development.
Lead clinical pharmacology and modelling & simulation efforts for infectious disease assets, applying pharmacokinetic/pharmacodynamic and population modelling to inform dose selection, trial design, and regulatory strategy. This senior individual contributor role combines hands-on quantitative analysis with strategic leadership across development phases, from early planning to lifecycle management. Work within a science-driven team to advance model-informed drug development using tools like NONMEM, R, and PBPK, while collaborating with cross-functional partners and supporting regulatory submissions.
This role involves advancing interdisciplinary research in materials and devices for life sciences, focusing on nanopore technologies, 3D tissue engineering, and device development for clinical diagnostics and therapeutics. The scientist will design experiments, refine emerging technologies, and contribute to high-impact publications in a collaborative, well-resourced environment. Work spans molecular sciences, nanotechnology, and bioengineering to create transformative biomedical tools.
Leads statistical strategy and execution for global clinical development projects in inflammation, immunology, and specialty care. Provides expert input on study design, analysis plans, and regulatory submissions while advancing innovative methodologies. Collaborates across functions to ensure high-quality, compliant statistical deliverables and supports publication and product defense activities.
Leads statistical strategy for global clinical development in inflammation, immunology, and specialty care, providing oversight on study design, analysis, and regulatory submissions. Manages cross-functional collaboration and drives innovation in statistical methodology. Works closely with clinical, regulatory, and data teams to ensure high-quality, compliant deliverables across the drug development lifecycle.
Lead statistical strategy for oncology clinical development, from study design through regulatory submission, using advanced methods like Bayesian approaches and real-world data. Partner with cross-functional teams to deliver robust analyses and influence key decisions. Drive innovation in trial design and evidence generation within a global biopharma environment.
Lead statistical strategy across oncology clinical development, from early-phase trials to registration, using innovative methods like Bayesian modelling and real-world data. Design studies, guide regulatory submissions, and influence asset strategy within a matrix environment. Work closely with cross-functional teams to deliver robust statistical insights for key decision-making.
This role involves providing statistical leadership across oncology clinical development, from early-phase trials to regulatory submissions. The candidate will design and analyze studies using advanced methods like Bayesian statistics, simulations, and real-world data, while collaborating with cross-functional teams. They will also drive innovation in statistical strategy and contribute to regulatory documentation and asset development.
Leads safety evaluation and risk management for GSK's oncology assets in clinical development, providing scientific expertise to assess and communicate safety risks globally. Works cross-functionally to shape safety strategy, support regulatory submissions, and ensure patient protection. Focuses on signal detection, risk assessment, and strategic decision-making in a matrix environment.
The Discovery Disease Area Lead for Cardiovascular-Renal Diseases at GSK will lead the identification and validation of therapeutic targets for chronic kidney disease, glomerulonephritis, and cardiovascular conditions. You will manage a cross-functional team, drive scientific excellence, and collaborate with external experts to translate human disease phenotype information into actionable therapeutic innovations.
The Director, Oncology Translational Medicine Project Manager, will lead project management for biomarker and diagnostic strategies across GSK’s global Oncology portfolio. Responsibilities include managing external alliances, regulatory submissions, and diagnostic target profiles, ensuring high-quality data and documentation support oncology asset development and approvals.
This role involves partnering with R&D technology programmes to create and deliver practical adoption plans for AI and digital tools. You will assess programme readiness, coordinate stakeholders, and measure the impact of new capabilities. The position requires strong project delivery and analytical skills, with a focus on driving organisational change and value creation.
This 12-month industrial placement offers hands-on experience in either Analytical or Synthetic Chemistry within GSK’s R&D environment in Stevenage. In the Analytical role, you’ll use techniques like HPLC, GC, and NMR in a GMP setting to support medicine development. The Synthetic Chemistry role involves designing and running experiments to create new compounds, working alongside experienced scientists in a multidisciplinary team. Both roles emphasize technical skill development, project ownership, and real-world impact in drug discovery.
This role leads the planning and execution of translational medicine strategies for GSK’s antibody-drug conjugate (ADC) oncology portfolio. The Director will integrate biomarker and diagnostic development with clinical programs, manage cross-functional teams, and ensure operational readiness for key milestones. They will provide strategic project management oversight, drive governance reporting, and support regulatory compliance across global oncology projects.
This role involves partnering with R&D technology programmes to create and deliver practical adoption plans for AI and digital tools. The Director will assess programme readiness, coordinate stakeholders, and measure the impact of new capabilities, ensuring they create value and are sustainably adopted across the organization.
